PressReleaseHeader

Medical Marijuana Inc. (OTC: MJNA) Patent Pending Extraction ---- Cannabidiol (CBD) Possible Use In The Anti-Tumor and Anti-Cancer Nutraceutical and Pharmaceutical Industries.

SAN DIEGO, CA--(Business Wire – Sept 2, 2011) - Medical Marijuana Inc (OTC: MJNA) is pleased to announce that studies have proven Cannabidiol (CBD) as an Anti-Tumor and Anti-Cancer agent. Currently Medical Marijuana Inc through CannaBANK has a patent pending on an extraction method from Cannabis and Hemp allowing Cannabidiol (CBD) to be isolated in its pure form. Research shows $200 billion a year is spent to treat Tumors and Cancer. The company is planning on expanding rapidly by allowing a heavily marketed nutraceutical or pharmaceutical company the use of its extraction technology through exclusive license agreements.

“Many qualified companies have shown great interest, and it won’t be long until we license the right one.” said a Medical Marijuana Inc spokesperson.Given the vast number of nutraceutical and pharmaceutical companies across the country, it’s no doubt that CBD can be easily formulated into an array of already heavily marketed products, quickly becoming a major component of health and wellness in the near future.Jared Berry, a CannaBANK executive stated. “Education is the key! The evidence is already overwhelming. Just look at what companies like GW Pharmaceutical’s is accomplishing with Sativex or simply google Cannabidiol (CBD) and the studies and research dedicated to this what’s called a ‘nutritional necessity’ is overwhelmingly obvious.” 

List of public studies on Cannabidiol as an Anti-Tumor and Anti-Cancer agent can be found within the following links:

Cancer Studies:

http://www.ncbi.nlm.nih.gov/pubmed/20053780

http://www.ncbi.nlm.nih.gov/pubmed/16728591

http://www.ncbi.nlm.nih.gov/pubmed/21566064

http://www.ncbi.nlm.nih.gov/pubmed/18833429

Tumor Studies:

http://www.ncbi.nlm.nih.gov/pubmed/18035205

http://www.ncbi.nlm.nih.gov/pubmed/14617682

Clinical Trials:

http://clinicaltrials.gov/ct2/results?term=cannabidiol

http://www.cannabis-med.org/studies/ww_en_db_study_search.php

ABOUT MEDICAL MARIJUANA INC (OTC: MJNA)

Our mission is to be the world's premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate, invest in and purchase value-added sustainable companies, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, pay homage to the visionaries and activists of the past and present, and provide the platform from which the industry can emerge into a global sustainable economy for all. Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.

www.medicalmarijuanainc.com

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the Food and Drug Administration, products and statements are not intended to diagnose, treat, cure, or prevent any disease.

Contact Information:

Medical Marijuana Inc.2665 Ariane Drive Suite 207

San Diego, CA 92117

888-OTC-MJNA (888-682-6562)

This email address is being protected from spambots. You need JavaScript enabled to view it.